BBA
GILD icon

Baader Bank Aktiengesellschaft’s Gilead Sciences GILD Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,000
Closed -$1.85M – 389
2022
Q3 		$1.85M Buy
+30,000
New +$1.89M 0.12% 159
2022
Q2 		– Sell
-2,000
Closed -$119K – 357
2022
Q1 		$119K Buy
+2,000
New +$128K 0.01% 240

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baader Bank Aktiengesellschaft's GILD Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft increased its Gilead Sciences (GILD) stake by 19% in Q1 2026, buying an estimated $186K and bringing the position to 8,320 shares worth $1.09M. The position accounts for 0.09% of the portfolio, ranked #166.

Baader Bank Aktiengesellschaft first reported a position in GILD in Q4 2021 and has held it in 12 quarters since. The position peaked at $9.35M in Q4 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 8,320 shares of Gilead Sciences worth $1.09M as of Q1 2026.
  • Baader Bank Aktiengesellschaft bought 1,327 Gilead Sciences shares in Q1 2026, an estimated $186K.
  • Gilead Sciences made up 0.09% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #166 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Gilead Sciences in Q4 2021 and has held it in 12 quarters since.
  • Baader Bank Aktiengesellschaft's Gilead Sciences position peaked at $9.35M in Q4 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.